Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC, explain how Mayo Clinic Laboratories' expanded test panel captures rarer as well as more common genetic causes of hereditary pancreatitis. That information is key to managing patients' enhanced risk for pancreatic cancer.

Speaker 4: (00:32)
Could you both please tell us a little bit about yourself and your background?

Speaker 4: (02:23)
Could you please give the audience a brief overview of this assay?

Speaker 4: (03:53)
Which patients should have this test, and when should it be performed?

Speaker 4: (04:49)
What alternative testing options are available, and how do these compare to the new, expanded panel that we're going to be offering?

Speaker 4: (08:20)

How are the results used in patient care?

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed. They explore:

• The significant interest in diagnostics for the advancement of cancer care.
• The Joint Commission’s collaboration with the Coalition for Health AI to establish guidelines for the responsible use of artificial intelligence.
• The growing understanding that platforms offer an opportunity to expand access and make knowledge more accessible as platform-driven solutions become a reality.
• The role of laboratorians in guiding the ethical and effective use of data and emerging technologies — and what this means for educating future healthcare professionals.
• The critical importance of values and ethics in deploying new tools.

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new test measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.

(00:32)
Can you tell us a little bit about yourself and your background?

(01:33)
Could you give us a brief overview of this assay?

(02:47)
Which patients should have this testing, and when should it be performed?

(03:48)
How would the results be used in patient care?